NCL-1

N/A

Report date: 2025/01/26 17:23:00
NME

Base Information

Drug NameNCL-1
Drug Alias NameLysine-specific demethylase 1 inhibitors (Nagoya City University)(1S,2R)-NCL-1(1R,2S)-NCL-1NCL-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsProstatic NeoplasmsTesticular Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNagoya City University
China Registration ClassN/A

Develop Information

Active CompaniesNagoya City University
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsTesticular Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A